Discover how lab automation, digital solutions and more are revolutionizing patient care as thought leaders share their insights.
Vergara will succeed and report to Brad Moore, president and CEO of Roche Diagnostics North America
Discover upcoming changes related to the termination of the EUA Declaration.
Discover the advancements in cervical-cancer diagnosis and its future.
The Elecsys® tTau/Abeta42 ratio helps clinicians define AD biologically and expands Roche’s AD CSF portfolio.
Learn more about our portfolio of lab instruments, systems, assays and more
More than 800,000 documents available on demand — always up-to-date with 24/7 access
Login to eLabDoc
Empowering learning — e-learning content, PACE/CEU courses, and more